Full title: Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study

Author/creator: RAD001 in Advanced Neuroendocrine Tumours, Fourth Trial (RADIANT-4) Study Group, Yao, James C, Dr, Fazio, Nicola, MD, Singh, Simron, MD, Buzzoni, Roberto, MD, Carnaghi, Carlo, MD, Wolin, Edward, MD, Tomasek, Jiri, MD, Raderer, Markus, MD, Lahner, Harald, MD, Voi, Maurizio, MD, Pacaud, Lida Bubuteishvili, MD, Rouyrre, Nicolas, MSc, Sachs, Carolin, RN, Valle, Juan W, MD, Fave, Gianfranco Delle, MD, Van Cutsem, Eric, MD, Tesselaar, Margot, MD, Shimada, Yasuhiro, MD, Oh, Do-Youn, MD, Strosberg, Jonathan, MD, Kulke, Matthew H, MD, Pavel, Marianne E, MD.

Call Numbers:

Record Identifier: TN_cdi_proquest_miscellaneous_1773426215

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1773426215